Metabolic Syndrome Program Area
Delineation of the biological processes that lead to obesity and its co-morbidities is fundamental to developing effective interventions and in predicting their risks. The metabolic syndrome program area will foster interaction among members from a broad range of disciplines to advance our understanding of mechanisms regulating energy intake, energy expenditure, triacylglyceride storage, adipogenesis, glucose metabolism, and obesity-related complications in cells, animal models, and humans.
Members of this program area are:
|
Rosalind Coleman, Head, Nutrition |
lipid metabolism |
| Melinda Beck Nutrition/Pediatrics |
immunological effects of obesity |
| Aysenil Belger
Psychiatry |
neuroimaging/food/anorexia/obesity |
| Terry Combs Nutrition |
adipose tissue in obesity etiology and associated co-morbidities |
| Kay Lund Cell and Molecular Physiology |
insulin/IGF’s, cytokine and adipokine signaling and cytokine/adipokine expression as related to gastrointestinal function and obesity. |
| Nobuyo Maeda Medicine |
genetics and molecular pathology of atherosclerosis; interactions between genetic and environmental factors |
| Miroslav Styblo Nutrition |
metabolic interactions of essential microelements, especially trace metals |
| Nobuyuki Takahashi Pathology and Lab Medicine |
interrelationship between obesity and genes that regulate blood pressure |
| Todd Thiele Alcohol Center |
obesity and alcoholism linked with peptides and melanocortins; leptin and GLP-1 |
